-
International Journal of Chronic Obstructive Pulmonary Disease
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Effect of bronchodilatation on single breath pulmonary uptake of carbon monoxide in chronic obstructive pulmonary disease
(1912) Views (369) Full article downloads
Authors: Simonetta Baldi, Claudio Fracchia, Claudio Bruschi, Roberto Dore, Roberto Maestri, et al
Published Date February 2006
Volume 2006:1(4) Pages 477 - 483
DOI: http://dx.doi.org/10.2147/COPD.S
Simonetta Baldi1, Claudio Fracchia1, Claudio Bruschi1, Roberto Dore2, Roberto Maestri1, Vito Brusasco3, Riccardo Pellegrino4
1U.O di Riabilitazione Specialistica Pneumologia Riabilitativa, Istituto Scientifico di Montescano, Fondazione Salvatore Maugeri IRCCS, 27040 Montescano, Pavia; 2Istituto di Radiologia Medica, Policlinico S. Matteo IRCCS, 27100, Pavia; 3Dipartimento di Medicina Interna, Università di Genova, 16132 Genova; 4Centro di Fisiopatologia Respiratoria e di Studio della Dispnea, Azienda Ospedaliera S.Croce e Carle, 12100 Cuneo; Italy
Abstract: We studied 21 COPD patients in stable clinical conditions to evaluate whether changes in lung function induced by cumulative doses of salbutamol alter diffusing capacity for carbon monoxide (DLCO), and whether this relates to the extent of emphysema as assessed by high resolution computed tomography (HRCT) quantitative analysis. Spirometry and DLCO were measured before and after cumulative doses of inhaled salbutamol (from 200 µg to 1000 µg). Salbutamol caused significant increments of forced vital capacity (FVC), forced expiratory volume in one second (FEV1), and flows at 30% of control FVC taken from both partial and maximal forced expiratory maneuvers. Functional residual capacity and residual volume were reduced, while total lung capacity did not change significantly. DLCO increased progressively with the incremental doses of salbutamol, but this became significant only at the highest dose (1000 µg) and was independent of the extent of emphysema, as assessed by radiological parameters. No significant changes were observed in CO transfer factor (DLCO/VA) and alveolar volume (VA). The results suggest that changes in lung function induced by cumulative doses of inhaled salbutamol are associated with a slight but significant increase in DLCO irrespective of the presence and extent of emphysema.
Keywords: lung volumes, high resolution computed tomography, chronic obstructive bronchitis, emphysema
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"You do a tremendous job!!" Ruben Restrepo, The University of Texas Health Science Center at San Antonio
- Clinical effectiveness of the Respimat® inhaler device in managing chronic obstructive pulmonary disease: evidence when compared with other handheld inhaler devices
- Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity
- The pathophysiology of bronchiectasis
- Exacerbation rate, health status and mortality in COPD – a review of potential interventions




